ThermoFisherScientific - Custom and Bulks
Pharma Focus Europe
Worldwide Clinical Trials - Neuroscience Clinical Development

LATEST NEWSRead more...

21

Jun 2024

C-Path and CENTOGENE Enhance Collaboration in Advancing Lysosomal Disease Research and Drug Development

The Critical Path Institute and Centogene NV have entered into a Memorandum of Understanding to collaborate on advancing drug development for lysosomal diseases and enhancing the quality

21

Jun 2024

Abzena and Argonaut Collaborate to Enhance Support for Biopharmaceutical Drug Development

Abzena a prominent contract development and manufacturing organization specializing in complex biologics and bioconjugates has formed a strategic partnership

21

Jun 2024

FDA Approves Expansion of Gene Therapy for Duchenne Muscular Dystrophy

The US Food and Drug Administration recently expanded its approval of Elevidys a gene therapy for Duchenne muscular dystrophy to include ambulatory and nonambulatory individuals aged years and older with a confirmed mutation in the DMD gene Initially Elevidys received accelerated approval

20

Jun 2024

Bit.bio Introduces ioAstrocytes, Enhancing Brain Modeling Capabilities for Researchers

Bitbio a pioneering company in synthetic biology focused on coding human cells for novel therapies has unveiled ioAstrocytes as its latest addition to the ioCells portfolio This new offering aims to revolutionize

19

Jun 2024

Neurona Therapeutics Obtains FDA RMAT Designation for NRTX-1001 in Treating Focal Epilepsy

Neurona Therapeutics a company in the clinical stage focusing on regenerative cell therapies for disorders of the nervous system has received RMAT designation from the FDA

19

Jun 2024

EUROAPI and Priothera Enter CDMO Agreement for an Oncology Project

EUROAPI has secured a fiveyear agreement with Priothera a biotechnology company that specializes in treatments for blood cancers and enhancements in CART cell therapies Priothera operates out of Dublin Ireland with an additional branch in SaintLouis France

press releasesRead more...

Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor

Jazz Pharmaceuticals plc today announced topline results from the Phase b clinical trial evaluating the efficacy and safety of suvecaltamide an investigational highly selective and statedependent modulator of Ttype calcium channels

Coya Therapeutics Expands Research Collaboration with Houston Methodist and Secures Funding to Advance T Cell Exosome Platform

Coya Therapeutics Inc a clinicalstage biotechnology company developing biologics intended to enhance regulatory T cell function announces the expansion

Basilea Partners Oncology Drug Candidate Lisavanbulin With Glioblastoma Foundation

Basilea Pharmaceutica Ltd Allschwil a biopharmaceutical company with marketed products dedicated to helping patients suffering from severe bacterial or fungal infections today announced

Rutherrin® Demonstrates Complete Response in Lung Cancer Preclinically

Theralase Technologies Inc a clinical stage pharmaceutical company dedicated to the research and development of light andor radiation activated small molecules and their formulations intended for the safe and effective

25 - 26

Jun 2024

25 - 27

Jun 2024

25 - 27

Jun 2024

Future Pharma

Boston, MA, USA

26 - 27

Jun 2024

Future Labs

Basel, Switzerland

26 - 27

Jun 2024

26 - 26

Jun 2024

08 - 10

Jul 2024
Thermo Fisher Scientific viral vector services (VVS)
ThermoFisher - Mastering API production at every scale
Future Labs Live - 2024
World Orphan Drug Congress 2024
World Vaccine Congress Europe 2024

TOP ARTICLES

  • 1

    Drug Safety in Focus: Challenges and Solutions for Pharma Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 2

    Medical Devices and Pharma: A Symbiotic Relationship for Improved Healthcare

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 4

    Navigating the Pharma Market: Strategies for Successful Pharmaceutical Sales

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 5

    Prescription Drugs and Personalized Medicine: A New Era in Pharma

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

KNOWLEDGE BANK

  • Techno Trends

    Novel Non-immunosuppressive Therapy to Treat Kidney-Related Disease

    A novel nonimmunosuppressive therapy FILSPARI sparsentan has been granted approval by the US Food and Drug Administration to treat IgA nephropathy IgAN Oral sparsentan is recommended to reduce proteinuria protein in the urine in patients at risk for disease progression because it targets the endothelin and angiotensin pathways both of which promote IgAN disease progr...

EDITORIAL SECTION